Treatment of myopic choroidal neovascularization: a network meta-analysis and review
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Treatment of myopic choroidal neovascularization: a network meta-analysis and review ; day:11 ; month:11 ; year:2023 ; pages:1-30
Graefe's archive for clinical and experimental ophthalmology ; (11.11.2023), 1-30
- Urheber
-
Glachs, Laura
Embacher, Stefan
Berghold, Andrea
Wildner, Brigitte
Michelitsch, Monja
Tscherne, Anna
Wedrich, Andreas
Posch-Pertl, Laura
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00417-023-06271-2
- URN
-
urn:nbn:de:101:1-2024013013095772051425
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.01.2025, 01:21 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Glachs, Laura
- Embacher, Stefan
- Berghold, Andrea
- Wildner, Brigitte
- Michelitsch, Monja
- Tscherne, Anna
- Wedrich, Andreas
- Posch-Pertl, Laura
- SpringerLink (Online service)
Ähnliche Objekte (12)
Long-Term Outcomes of High-Dose Conbercept Treatment for Myopic Choroidal Neovascularization and Idiopathic Choroidal Neovascularization
Result of intravitreal aflibercept injection for myopic choroidal neovascularization
Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
Insights into myopic choroidal neovascularization based on quantitative proteomics analysis of the aqueous humor
Effect of intravitreal injection of aflibercept or ranibizumab on chorioretinal atrophy in myopic choroidal neovascularization
Inflammasome activation aggravates choroidal neovascularization
MiRNA-21-HIF-1α-VEGF Axis Is Associated with Myopic Choroidal Neovascularization in Guinea Pigs
A new model of choroidal neovascularization
Peripapillary choroidal neovascularization in pars planitis
Myopic choroidal neovascularization with neovascular signal around perforating scleral vessel prone to recur after anti-VEGF therapy
Long-term outcomes of anti-vascular endothelial growth factor therapy with and without posterior scleral reinforcement on myopic maculopathy in myopic choroidal neovascularization eyes
Retinal vascular changes and aqueous humor cytokines changes after aflibercept intravitreal injection in treatment-naïve myopic choroidal neovascularization
Long-Term Outcomes of High-Dose Conbercept Treatment for Myopic Choroidal Neovascularization and Idiopathic Choroidal Neovascularization
Result of intravitreal aflibercept injection for myopic choroidal neovascularization
Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
Insights into myopic choroidal neovascularization based on quantitative proteomics analysis of the aqueous humor
Effect of intravitreal injection of aflibercept or ranibizumab on chorioretinal atrophy in myopic choroidal neovascularization
Inflammasome activation aggravates choroidal neovascularization
MiRNA-21-HIF-1α-VEGF Axis Is Associated with Myopic Choroidal Neovascularization in Guinea Pigs
A new model of choroidal neovascularization
Peripapillary choroidal neovascularization in pars planitis
Myopic choroidal neovascularization with neovascular signal around perforating scleral vessel prone to recur after anti-VEGF therapy
Long-term outcomes of anti-vascular endothelial growth factor therapy with and without posterior scleral reinforcement on myopic maculopathy in myopic choroidal neovascularization eyes
Retinal vascular changes and aqueous humor cytokines changes after aflibercept intravitreal injection in treatment-naïve myopic choroidal neovascularization
Long-Term Outcomes of High-Dose Conbercept Treatment for Myopic Choroidal Neovascularization and Idiopathic Choroidal Neovascularization
Result of intravitreal aflibercept injection for myopic choroidal neovascularization
Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
Insights into myopic choroidal neovascularization based on quantitative proteomics analysis of the aqueous humor
Effect of intravitreal injection of aflibercept or ranibizumab on chorioretinal atrophy in myopic choroidal neovascularization
Inflammasome activation aggravates choroidal neovascularization
MiRNA-21-HIF-1α-VEGF Axis Is Associated with Myopic Choroidal Neovascularization in Guinea Pigs
A new model of choroidal neovascularization
Peripapillary choroidal neovascularization in pars planitis
Myopic choroidal neovascularization with neovascular signal around perforating scleral vessel prone to recur after anti-VEGF therapy
Long-term outcomes of anti-vascular endothelial growth factor therapy with and without posterior scleral reinforcement on myopic maculopathy in myopic choroidal neovascularization eyes